Advanced Practitioner Society For Hematology And Oncology

What Advanced Practitioner Society For Hematology And Oncology does

Advanced Practitioner Society for Hematology and Oncology (APSHO) is a 501(c)(6) nonprofit professional membership society founded in 2014 and headquartered in Hightstown, New Jersey. APSHO exclusively serves advanced practitioners working in hematology and oncology, including nurse practitioners, physician assistants, clinical nurse specialists, advanced degree nurses, and oncology pharmacists. The society's core mission is to improve the quality of cancer care by providing professional development, continuing education, peer networking, and advocacy for the AP workforce. It is managed by Harborside and governed by a Board of Directors with mandated representation from NPs, PAs, and pharmacists.

APSHO's product portfolio centers on JADPRO, the only peer-reviewed, indexed journal written for and by oncology APs, and JADPRO Live, a triple-accredited annual conference drawing 1,500+ attendees. Additional offerings include the AP Academy online learning platform (hosting courses such as the Cancer Therapy Prescription Course, DEA Training Course, and APRO Course), the Mentor Match mentorship program, AP Toolkits for complex therapies (bispecific antibodies, ADCs, CAR-T, systemic mastocytosis), Educator Modules, Case-Based Learning resources, and the APSHO Online Community. The underlying technology platform is powered by YourMembership software, providing membership management, learning management, and community portal functionality.

APSHO generates revenue through recurring membership dues ($95/year Professional, $220/year Associate, free Student, and tiered group pricing from $430 for 5 seats to $7,000 for 100 seats), conference and CE/CNE/CPE course fees, institutional membership contracts, and Industry Council sponsorships from 12+ major pharmaceutical and biotech companies including AbbVie, Amgen, AstraZeneca, BMS, Genentech, Gilead-Kite, GSK, Johnson & Johnson, Lilly, Merck, and Pfizer. The society does not have external investors or parent company ownership, operating on a member-governed nonprofit basis with thousands of members across the United States.

Name

Advanced Practitioner Society For Hematology And Oncology

Legal name

Advanced Practitioner Society For Hematology And Oncology

Website

https://apsho.org

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

APSHO is a 501(c)(6) nonprofit professional society founded in 2014 that provides oncology-specific education, peer networking, and advocacy for advanced practitioners, including nurse practitioners, physician assistants, pharmacists, and clinical nurse specialists in hematology and oncology.

Ownership category

akta.pro rank

Product category

Professional Medical Association and Oncology Continuing Education

SIC

Services-Membership Organizations (8600)

akta.pro primary industry

Clinical Research Support (CRC/CTA) (EDAOAJAO)

Keywords

• Oncology professional association
• Continuing education healthcare
• Advanced practitioner society
• Hematology medical education
• Professional membership services

Headquarters

HQ city

Hightstown

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others

Revenue model

1. Professional Membership Dues: Annual and biennial membership fees ranging from $95/year for individual professional members to $160 for 2-year terms. This is the primary recurring revenue stream supporting the society's operations and member services.
2. Associate Membership Dues: Non-qualifying individuals including physicians, medical students, and pharmaceutical industry employees pay $220/year for associate membership with limited benefits.
3. Conference and CE Fees: Revenue from JADPRO Live annual conference registration, JADPRO Regional Education conferences, and CE/CNE/CPE credits from AP Academy courses. Early bird and member discounts are offered.
4. Group and Institutional Memberships: Group pricing for 5-100 seats at discounted rates ($430-$7,000) and institutional memberships for organizations with over 100 advanced practitioners, providing volume-based revenue.
5. Industry Council Sponsorships: Pharmaceutical and biotech companies (AbbVie, Amgen, AstraZeneca, BMS, Genentech, Gilead, GSK, Johnson & Johnson, Lilly, Merck, Pfizer, and others) participate in the Industry Council, providing financial support in exchange for engagement with oncology APs.

Pricing tiers

Go-to-market motion2 records

Distribution channels7 records

Marketing channels10 records

Core offering

APSHO is a 501(c)(6) nonprofit professional membership society that supports nurse practitioners, physician assistants, clinical nurse specialists, advanced practice nurses, and pharmacists working in hematology and oncology. It sells individual, group, and institutional memberships, runs the peer-reviewed JADPRO journal, the JADPRO Live annual conference, and the AP Academy online continuing education platform, and provides mentorship, clinical toolkits, and networking resources for oncology advanced practitioners.

Product overview

APSHO is a professional membership society, not a technology product company. Its offerings consist of membership-based professional development services, educational programs, publications, and networking resources for advanced practitioners in hematology and oncology. The core portfolio includes: JADPRO (peer-reviewed journal) and JADPRO Live (annual conference) as flagship educational offerings; the APSHO AP Academy (online learning platform) hosting courses like the Cancer Therapy Prescription Course; Educator Modules and Case-Based Learning as clinical education resources; AP Toolkits (Bispecific Therapies, Systemic Mastocytosis) for practice guidance; the APSHO Mentorship Program and APSHO Fellows credential for professional development; the APSHO Career Center for job opportunities; the APSHO Online Community for peer networking; and the APSHO Seal of Acceptance program for evaluating educational materials. Additional offerings include APSHO Patient Compass (patient resources), APSHO Empowered video series, and the APSHO Foundation (scholarship/grant programs). The society also provides CE/CME credits and publishes the APSHO Advance quarterly newsletter.

Differentiator

Problem solved

Functional benefit

Brands

• JADPRO: Journal of the Advanced Practitioner in Oncology - the official peer-reviewed journal of APSHO, providing clinically relevant, evidence-based practice information for oncology advanced practitioners.
• JADPRO Live
• AP Academy
• APSHO Advance Newsletter
• APSHO Foundation
• APSHO Industry Council
• APSHO Empowered

Products and services

• JADPRO (Journal of the Advanced Practitioner in Oncology) Official peer-reviewed, indexed journal of APSHO providing clinically relevant, evidence-based practice information written for and by advanced practitioners in oncology.
• JADPRO Live Annual Conference Triple-accredited annual conference for oncology advanced practitioners featuring education, networking, poster presentations, and CE/CNE/CPE credits. The sixth conference in 2019 attracted more than 1,500 attendees.
• AP Academy Online Learning Platform Premier online educational resource for hematology and oncology advanced practitioners offering self-paced courses including the Cancer Therapy Prescription Course (CTPC), APRO Course, and DEA Training Course.
• APSHO Mentorship Program (Mentor Match) Structured mentorship matching platform connecting experienced oncology advanced practitioner mentors with mentees seeking career guidance, including a new 3-month Guided Mentorship Program.
• APSHO Online Community Member-exclusive online community platform for peer collaboration, strategic advice sharing, and professional networking among oncology advanced practitioners.
• APSHO Career Center Career opportunity listings and job board platform specifically for oncology advanced practitioners.
• Educator Modules Library of slide presentations covering topics such as CAR T-cell therapy, bispecific antibodies, antibody-drug conjugates, BTK inhibitors, biosimilars, and other oncology subjects, with audio download features.
• AP Toolkits Practical clinical toolkits including Operationalizing Bispecific Therapies in Practice and Toolkit for Systemic Mastocytosis, providing guidance organized by practice setting.
• Case-Based Learning Real-world patient case studies with expert insights covering CAR T-cell therapy, bispecific antibodies, drug delivery, geriatric oncology, and prostate cancer disparities.
• APSHO Seal of Acceptance Quality assurance program evaluating oncology/hematology educational materials and programs for consistency with standards of practice and quality care, valid for 1 year from approval.
• APSHO Patient Compass Tools and guides to help patients make informed, empowered cancer care decisions, including educational guides on biomarker reports and cancer advocacy group connections.
• APSHO Empowered Video Series Video series featuring APSHO members providing practical career advice and empowerment content for oncology advanced practitioners.
• APSHO Foundation Foundation supporting education, leadership development, and research for oncology/hematology advanced practitioners, offering scholarships including the JADPRO Live Scholarship.
• APSHO Fellows (FAPO) Fellow of Advanced Practice in Oncology credential recognizing excellence in oncology practice and contributions to the profession.
• APSHO Professional Membership Annual or biennial membership subscription for qualifying oncology advanced practitioners at $95/year or $160 for 2 years, providing access to member benefits, JADPRO journal, discounts, and CE resources.
• APSHO Group and Institutional Memberships Volume-based group memberships for 5-100 seats ($430-$7,000) and institutional memberships for organizations with over 100 advanced practitioners, providing group access to CE and benefits.
• APSHO Resource Center Curated collection of resources, toolkits, and materials for advanced practitioners, including links to clinical guidelines and educational content.

Named customers3 records

Segments6 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

17 partnerships are on record, tiered core and minor.

• AbbViecoreGTM or Marketing PartnerAbbVie is an Industry Council member of APSHO, supporting the society's mission to advance oncology AP practice. AbbVie's mission focuses on immunology, oncology, neuroscience, and other therapeutic areas. The partnership enables engagement with oncology APs through APSHO's professional community and educational resources.
• AmgencoreGTM or Marketing PartnerAmgen is an Industry Council member and provided support for the APSHO AP Toolkit for Bispecific Therapies. As a biotechnology pioneer since 1980, Amgen focuses on innovative human therapeutics for serious illnesses.
• AstraZenecacoreGTM or Marketing PartnerAstraZeneca is an Industry Council member, focusing on oncology, cardiovascular, renal & metabolism, and respiratory therapies. The partnership supports APSHO's educational initiatives for oncology APs.
• Bristol-Myers Squibb CompanycoreGTM or Marketing PartnerBMS is an Industry Council member committed to discovering and delivering innovative medicines that help patients prevail over serious diseases, including oncology.
• Eisai Co., Ltd.minorGTM or Marketing PartnerEisai is an Industry Council member with key areas including oncology and specialty care (Alzheimer's disease, epilepsy, metabolic disorders).
• Genentech (Roche Group)coreGTM or Marketing PartnerGenentech is an Industry Council member and provided support for the APSHO AP Toolkit for Bispecific Therapies. Founded over 35 years ago, Genentech discovers, develops, and commercializes medicines for serious medical conditions.
• GenmabminorGTM or Marketing PartnerGenmab is an Industry Council member and international biotechnology company developing innovative antibody therapeutics for cancer and serious diseases.
• GeronminorGTM or Marketing PartnerGeron is an Industry Council member focused on development and commercialization of therapies in hematologic malignancies.
• Gilead - KitecoreGTM or Marketing PartnerGilead and Kite Oncology are Industry Council members working to transform cancer treatment through next-generation therapies including antibody-drug conjugates, small molecules, and cell therapy approaches.
• GSK (Glaxo Smith & Kline)coreGTM or Marketing PartnerGSK is an Industry Council member focused on maximizing patient survival through transformational medicines in immuno-oncology, cell therapy, tumor targeting, and synthetic lethality.
• Jazz PharmaceuticalsminorGTM or Marketing PartnerJazz Pharmaceuticals is an Industry Council member dedicated to developing life-changing medicines for people with serious diseases in neuroscience and oncology.
• Johnson & JohnsoncoreGTM or Marketing PartnerJohnson & Johnson is an Industry Council member with expertise in Innovative Medicine and MedTech, focusing on preventing, treating, and curing complex diseases including cancer.
• Eli Lilly and CompanycoreGTM or Marketing PartnerLilly is an Industry Council member dedicated to delivering life-changing medicines for people with cancer for over 50 years, including Loxo Oncology at Lilly.
• MerckcoreGTM or Marketing PartnerMerck is an Industry Council member committed to translating breakthrough science into innovative oncology medicines, with one of the largest oncology development programs in the industry.
• Pfizer OncologycoreGTM or Marketing PartnerPfizer Oncology is an Industry Council member with an industry-leading portfolio of 24 approved innovative cancer medicines and biosimilars across more than 30 indications.
• Cancer Advocacy OrganizationscoreStrategic or Co-development PartnerAPSHO collaborates with leading cancer advocacy organizations including Susan G. Komen, American Cancer Society, CancerCare, LUNGevity Foundation, Tigerlily Foundation, PANcan, and The Cancer Network through the APSHO Patient Advocacy Council to enhance patient care and support.
• Empowered with Meg RyanminorGTM or Marketing PartnerAPSHO partnered with Empowered with Meg Ryan to spotlight the vital role of advanced practitioners in cancer care through a special 'No One Fights Alone' episode featuring actress Meg Ryan.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Market position

Competitive moat5 records

Key highlights7 records

Customer concentration

• Xx.com/APSHOorg
• Facebookfacebook.com/AdvancedPractitionerSociety
• LinkedInlinkedin.com/company/advanced-practitioner-society-for-hematology-and-oncology-apsho-
• Instagraminstagram.com/apshoorg

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Advanced Practitioner Society For Hematology And Oncology